Protara Therapeutics (TARA)
(Delayed Data from NSDQ)
$2.00 USD
-0.02 (-0.99%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $1.99 -0.01 (-0.50%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth A Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/1/24 |
---|---|
Current Quarter | -0.50 |
EPS Last Quarter | -0.45 |
Last EPS Surprise | 45.12% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.96 |
Next Year | -2.99 |
EPS (TTM) | -3.19 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.50 | -0.51 | -2.96 | -2.99 |
# of Estimates | 2 | 2 | 4 | 4 |
Most Recent Consensus | -0.48 | -0.51 | -2.22 | -2.67 |
High Estimate | -0.48 | -0.51 | -2.00 | -1.54 |
Low Estimate | -0.52 | -0.51 | -5.35 | -5.95 |
Year ago EPS | -0.87 | -0.90 | -3.57 | -2.96 |
Year over Year Growth Est. | 42.53% | 43.33% | 17.09% | -1.18% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 2 | 2 | 2 | 2 |
Up Last 60 Days | 2 | 2 | 2 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.50 | -0.51 | -2.96 | -2.99 |
7 Days Ago | -0.50 | -0.51 | -2.96 | -2.99 |
30 Days Ago | -0.86 | -0.88 | -3.56 | -3.59 |
60 Days Ago | -0.86 | -0.88 | -3.56 | -3.59 |
90 Days Ago | -0.86 | -0.88 | -3.56 | -3.59 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.50 | -0.51 | -2.24 | -2.11 |
Zacks Consensus Estimate | -0.50 | -0.51 | -2.96 | -2.99 |
Earnings ESP | 0.00% | 0.00% | 24.26% | 29.66% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.45 | -0.97 | -0.90 | -0.87 | NA |
Estimate | -0.82 | -0.99 | -1.03 | -1.10 | NA |
Difference | 0.37 | 0.02 | 0.13 | 0.23 | 0.19 |
Surprise | 45.12% | 2.02% | 12.62% | 20.91% | 20.17% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more